CPT code 50574 denotes a percutaneous endoscopic renal and ureteral evaluation with biopsy, a procedure used to visualize the renal pelvis and ureter and to obtain renal tissue for diagnostic purposes. Nationally, this code is relevant for managing complex urologic diagnoses where direct visualization and histologic sampling of renal tissue influence treatment planning and staging. The code applies to procedures commonly performed in ambulatory surgery centers and hospital operating rooms by urology teams.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, common settings of care, and typical procedure elements tied to CPT code 50574. The publication also summarizes common modifiers and coding considerations, payer coverage patterns, and benchmarking elements relevant to facility and professional billing. Policy and reimbursement trends that affect utilization and documentation expectations are highlighted, along with operational notes on service lines and typical billing scenarios.

This executive summary prepares clinicians, billing professionals, and policy analysts to understand the code’s clinical role, where it is typically performed, and the payer landscape that influences coverage and reimbursement at a national level.